Class information for:
Level 2: HPMA COPOLYMERS//HPMA COPOLYMER//PEGYLATION

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2307 4094 41.1 74%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
449 23681 SOLID LIPID NANOPARTICLES//L ASPARAGINASE//NANOSTRUCTURED LIPID CARRIERS

Classes in level below (level 1)


ID, lev. below Publications Label for level below
5170 1593 PEGYLATION//MONOMETHOXYPOLYETHYLENE GLYCOL//BRANCHED PEG
7275 1310 HPMA COPOLYMERS//HPMA COPOLYMER//POLYMER THER EUT
15534 637 ANTIBODY DRUG CONJUGATE//ANTIBODY DRUG CONJUGATES//T DM1
19601 433 GRP PEPTIDE CHEM//BRANCHED POLYPEPTIDES//HUNGARIAN SCI PEPTIDE CHEM GRP
31589 121 WIG 1//OSTEOACTIVIN//GPNMB

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 HPMA COPOLYMERS Author keyword 137 91% 1% 58
2 HPMA COPOLYMER Author keyword 79 75% 1% 57
3 PEGYLATION Author keyword 63 24% 6% 228
4 POLYMER THER EUT Address 51 55% 2% 64
5 POLYMER THERAPEUTICS Author keyword 43 54% 1% 55
6 MONOMETHOXYPOLYETHYLENE GLYCOL Author keyword 36 83% 0% 20
7 ANTIBODY DRUG CONJUGATE Author keyword 33 44% 1% 56
8 ANTIBODY DRUG CONJUGATES Author keyword 32 51% 1% 45
9 N 2 HYDROXYPROPYLMETHACRYLAMIDE COPOLYMERS Author keyword 31 92% 0% 12
10 WIG 1 Author keyword 26 100% 0% 11

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 HPMA COPOLYMERS 137 91% 1% 58 Search HPMA+COPOLYMERS Search HPMA+COPOLYMERS
2 HPMA COPOLYMER 79 75% 1% 57 Search HPMA+COPOLYMER Search HPMA+COPOLYMER
3 PEGYLATION 63 24% 6% 228 Search PEGYLATION Search PEGYLATION
4 POLYMER THERAPEUTICS 43 54% 1% 55 Search POLYMER+THERAPEUTICS Search POLYMER+THERAPEUTICS
5 MONOMETHOXYPOLYETHYLENE GLYCOL 36 83% 0% 20 Search MONOMETHOXYPOLYETHYLENE+GLYCOL Search MONOMETHOXYPOLYETHYLENE+GLYCOL
6 ANTIBODY DRUG CONJUGATE 33 44% 1% 56 Search ANTIBODY+DRUG+CONJUGATE Search ANTIBODY+DRUG+CONJUGATE
7 ANTIBODY DRUG CONJUGATES 32 51% 1% 45 Search ANTIBODY+DRUG+CONJUGATES Search ANTIBODY+DRUG+CONJUGATES
8 N 2 HYDROXYPROPYLMETHACRYLAMIDE COPOLYMERS 31 92% 0% 12 Search N+2+HYDROXYPROPYLMETHACRYLAMIDE+COPOLYMERS Search N+2+HYDROXYPROPYLMETHACRYLAMIDE+COPOLYMERS
9 WIG 1 26 100% 0% 11 Search WIG+1 Search WIG+1
10 OSTEOACTIVIN 26 80% 0% 16 Search OSTEOACTIVIN Search OSTEOACTIVIN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 N 2 HYDROXYPROPYL METHACRYLAMIDE COPOLYMERS 114 95% 1% 38
2 ENZYMATICALLY DEGRADABLE BONDS 104 76% 2% 73
3 SITE SPECIFIC PEGYLATION 99 65% 2% 95
4 NATURAL MACROMOLECULES 81 96% 1% 25
5 N 2 HYDROXYPROPYLMETHACRYLAMIDE COPOLYMERS 77 64% 2% 76
6 PEGYLATION 57 28% 4% 175
7 OLIGOPEPTIDE SEQUENCES 48 91% 0% 20
8 DC HIL 44 85% 1% 23
9 BOUND ADRIAMYCIN 42 94% 0% 15
10 PROTEIN PEGYLATION 41 43% 2% 72

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Chemistry for peptide and protein PEGylation 2002 853 43 72%
The dawning era of polymer therapeutics 2003 1763 105 45%
Site-specific antibody drug conjugates for cancer therapy 2014 54 67 54%
Polymer conjugates as anticancer nanomedicines 2006 881 100 57%
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo 2013 189 74 31%
PEGylation, successful approach to drug delivery 2005 809 37 57%
PEGylation of therapeutic proteins 2010 206 73 68%
Antibody-drug conjugates: targeted drug delivery for cancer 2010 201 43 67%
Antibody- Drug Conjugates: An Emerging Concept in Cancer Therapy 2014 61 124 35%
Antibody-Drug Conjugates in Cancer Therapy 2013 108 60 48%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 POLYMER THER EUT 51 55% 1.6% 64
2 INNOVAT CANC DIAG THER Y 15 88% 0.2% 7
3 PHARMACEUT PHARMACEUT CHEM 13 12% 2.6% 108
4 CCCD 9 30% 0.6% 25
5 UTAH PHOTOMED 8 100% 0.1% 5
6 GRP PEPTIDE CHEM 7 15% 1.0% 40
7 CLIN COOPERAT UNIT RADIOTHER EUT ONCOL 6 53% 0.2% 8
8 BOLDERPATH INC 5 60% 0.1% 6
9 MICROBIOL ONCOL 5 25% 0.5% 19
10 PHARMACEUT PHARMACEUT CHEM CCCD 5 45% 0.2% 9

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000030173 POLYNUCLEOTIDE ANALOGUE//QUIM FARMACEUT ORGAN//BENZODIOXEPINS
2 0.0000024589 ALPHA BETA POLYN 2 HYDROXYETHYL DL ASPARTAMIDE//N CARBOXYANHYDRIDES//POLYSUCCINIMIDE
3 0.0000023641 SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//NANOSUSPENSION
4 0.0000018332 L ASPARAGINASE//ASPARAGINASE//ERWINIA ASPARAGINASE
5 0.0000017435 CAMPTOTHECIN//SN 38//TOPOTECAN
6 0.0000014789 RADIOIMMUNOTHERAPY//BISPECIFIC ANTIBODIES//EP CAM
7 0.0000013600 RIBOSOME INACTIVATING PROTEINS//RICIN//TRICHOSANTHIN
8 0.0000011435 CELL PENETRATING PEPTIDE//CELL PENETRATING PEPTIDES//PROTEIN TRANSDUCTION DOMAINS
9 0.0000010902 CARRIER ERYTHROCYTES//VASCULAR IMMUNOTARGETING//NANOERYTHROSOMES
10 0.0000009750 LIVING POLYMERIZATION//MACROMOL ENGN//ATOM TRANSFER RADICAL POLYMERIZATION ATRP